Selling by month
Mar 2026 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, since March 18, 2026. Nothing here rates or predicts.
- Sold in 3 of the 8 calendar months from Mar 2026 to Oct 2026: Apr 2026, Jun 2026 and Sep 2026.
- Largest single sale: $1.1M (30,000 shares) of Pharvaris N.V. on Sep 10, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Pharvaris N.V. (PHVS) | Chief Early Development | Mar 18, 2026 | Sep 21, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 17, 2026, Pharvaris N.V.: sold 20,000 shares for $765K, no plan disclosed (some held indirectly). 1 filing: 1
- Sep 10, 2026, Pharvaris N.V.: sold 30,000 shares for $1.1M, under a disclosed plan; 30,000 shares vested or acquired by exercising options. 1 filing: 1
- Jun 30, 2026, Pharvaris N.V.: sold 58,575 shares for $2.1M, under a disclosed plan; 27,872 shares acquired by exercising options (some held indirectly). 1 filing: 1
- Jun 29, 2026, Pharvaris N.V.: sold 17,597 shares for $617K, under a disclosed plan; 9,700 shares acquired by exercising options; 900 shares vested or acquired by exercising options (some held indirectly). 1 filing: 1
- Jun 25, 2026, Pharvaris N.V.: sold 4,600 shares for $162K, under a disclosed plan; 2,300 shares acquired by exercising options (some held indirectly). 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.